The results indicated that CER, LN, HDL-C, TG, PLT, Sex, and Apo-A1 were independent risk factors for advanced hepatic fibrosis in WD patients undergoing long-term maintenance therapy (P < 0.05). This evidence concerns the gene APOA1 and Hepatic fibrosis.